MEETINGS - Conference entitled Funding and reimbursement for medical technology - the latest on the European market (Belgium) April 2001:
This article was originally published in Clinica
IBC conferences in the UK will hold a conference entitled Funding and reimbursement for medical technology - the latest on the European market in Brussels, Belgium, on April 3. The meeting will address funding and reimbursement trends across Europe and future challenges of healthcare financing; and the EUCOMED position paper on health technology assessment for medical devices. Clinica's Amanda Maxwell will chair the afternoon panel discussion. For more information contact IBC conferences in the UK. Tel: +44 (0) 20 7453 5492. Fax: +44 (0) 20 7636 6858. Email: firstname.lastname@example.org www.healthcare-info.co.uk/reimbursement
You may also be interested in...
The French drugmaker is paying $2.5bn to get hold of THOR-707 which it claims has the potential to become the best-in-class IL-2 therapeutic for solid tumors, thanks to improved pharmacology and less frequent dosing.
For the first time, a working group within the International Council for Harmonization has started work on a regulatory topic specifically tailored to the global generics and biosimilars industry.
In 2019, Mylan moved up to become the world’s leading generics, biosimilars and OTC player, according to Informa Pharma Intelligence’s latest global rankings. Sandoz has surpassed troubled Teva into second place but is set to surrender that position following the sale of its US solid-dose and dermatology business to India’s Aurobindo.